Figure S4 from β-Cryptoxanthin Synergistically Enhances the Antitumoral Activity of Oxaliplatin through Δ<i>NP73</i> Negative Regulation in Colon Cancer

Figure S4 from β-Cryptoxanthin Synergistically Enhances the Antitumoral Activity of Oxaliplatin through Δ<i>NP73</i> Negative Regulation in Colon Cancer

<p>Figure S4. Quantification of cell viability by MTT assay. Combined treatment of 50 and 20 ÂµM oxaliplatin and 10 ÂµM Î²-cryptoxanthin in (A) HCT116 and (B) SW480-ADH cells respectively, leads to similar percentage of cell viability reduction to those produced by a double dose of oxaliplatin...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Coral San Millán (14998140) (author)
مؤلفون آخرون:	Beatriz Soldevilla (457149) (author), Paloma Martín (144198) (author), Beatriz Gil-Calderón (14998143) (author), Marta Compte (7506) (author), Belén Pérez-Sacristán (457150) (author), Encarnación Donoso (14998146) (author), Cristina Peña (84374) (author), Jesús Romero (14998149) (author), Fernando Granado-Lorencio (457152) (author), Félix Bonilla (84380) (author), Gemma Domínguez (84375) (author)
منشور في:	2023
الموضوعات:	Cancer Therapeutic Research and Development Methods and Technology Chemotherapy Adjuvant chemotherapy Combination chemotherapy Drug Discovery Technologies Natural products Drug Resistance Clinical drug resistance Novel mechanisms Regulation of gene expression in drug resistance Reversal of drug resistance Drug Targets Gastrointestinal Cancers Colorectal cancer Small Molecule Agents
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة

Figure S5 from β-Cryptoxanthin Synergistically Enhances the Antitumoral Activity of Oxaliplatin through Δ<i>NP73</i> Negative Regulation in Colon Cancer
حسب: Coral San Millán (14998140)
منشور في: (2023)

Figure S6 from β-Cryptoxanthin Synergistically Enhances the Antitumoral Activity of Oxaliplatin through Δ<i>NP73</i> Negative Regulation in Colon Cancer
حسب: Coral San Millán (14998140)
منشور في: (2023)

Figure S7 from β-Cryptoxanthin Synergistically Enhances the Antitumoral Activity of Oxaliplatin through Δ<i>NP73</i> Negative Regulation in Colon Cancer
حسب: Coral San Millán (14998140)
منشور في: (2023)

Figure S8 from β-Cryptoxanthin Synergistically Enhances the Antitumoral Activity of Oxaliplatin through Δ<i>NP73</i> Negative Regulation in Colon Cancer
حسب: Coral San Millán (14998140)
منشور في: (2023)

Figure S2-S3 from β-Cryptoxanthin Synergistically Enhances the Antitumoral Activity of Oxaliplatin through Δ<i>NP73</i> Negative Regulation in Colon Cancer
حسب: Coral San Millán (14998140)
منشور في: (2023)

Table S1-S2 from β-Cryptoxanthin Synergistically Enhances the Antitumoral Activity of Oxaliplatin through Δ<i>NP73</i> Negative Regulation in Colon Cancer
حسب: Coral San Millán (14998140)
منشور في: (2023)

Supplementary Figure 2 from Inhibition of Ataxia-Telangiectasia Mutated and RAD3-Related (<i>ATR</i>) Overcomes Oxaliplatin Resistance and Promotes Antitumor Immunity in Colorectal Cancer
حسب: Eve Combès (5626175)
منشور في: (2023)

Supplementary Figure S1 from Inhibition of Ataxia-Telangiectasia Mutated and RAD3-Related (<i>ATR</i>) Overcomes Oxaliplatin Resistance and Promotes Antitumor Immunity in Colorectal Cancer
حسب: Eve Combès (5626175)
منشور في: (2023)

Supplementary Figure S3 from Inhibition of Ataxia-Telangiectasia Mutated and RAD3-Related (<i>ATR</i>) Overcomes Oxaliplatin Resistance and Promotes Antitumor Immunity in Colorectal Cancer
حسب: Eve Combès (5626175)
منشور في: (2023)

Supplementary Table S1 from Inhibition of Ataxia-Telangiectasia Mutated and RAD3-Related (<i>ATR</i>) Overcomes Oxaliplatin Resistance and Promotes Antitumor Immunity in Colorectal Cancer
حسب: Eve Combès (5626175)
منشور في: (2023)

Supplementary S1 from Osimertinib (AZD9291) Enhanced the Efficacy of Chemotherapeutic Agents in ABCB1- and ABCG2-Overexpressing Cells <i>In Vitro, In Vivo</i>, and <i>Ex Vivo</i>
حسب: Zhen Chen (129176)
منشور في: (2023)

Data Supplement from Afatinib Enhances the Efficacy of Conventional Chemotherapeutic Agents by Eradicating Cancer Stem–like Cells
حسب: Xiao-kun Wang (287946)
منشور في: (2023)

Data Supplement from Afatinib Enhances the Efficacy of Conventional Chemotherapeutic Agents by Eradicating Cancer Stem–like Cells
حسب: Xiao-kun Wang (287946)
منشور في: (2023)

Data Supplement from Afatinib Enhances the Efficacy of Conventional Chemotherapeutic Agents by Eradicating Cancer Stem–like Cells
حسب: Xiao-kun Wang (287946)
منشور في: (2023)

Data Supplement from Afatinib Enhances the Efficacy of Conventional Chemotherapeutic Agents by Eradicating Cancer Stem–like Cells
حسب: Xiao-kun Wang (287946)
منشور في: (2023)

Supplementary Figures S1-S10 Tables S1-S3 from Disulfiram when Combined with Copper Enhances the Therapeutic Effects of Temozolomide for the Treatment of Glioblastoma
حسب: Xueqing Lun (77940)
منشور في: (2023)

Supplementary Figures from Upregulation of IGF1R by Mutant <i>RAS</i> in Leukemia and Potentiation of <i>RAS</i> Signaling Inhibitors by Small-Molecule Inhibition of IGF1R
حسب: Ellen Weisberg (203474)
منشور في: (2023)

Supplementary Fig. S1 from Cotargeting HSP90 and Its Client Proteins for Treatment of Prostate Cancer
حسب: Long Chen (315739)
منشور في: (2023)

Supplementary Methods and Materials from Cotargeting HSP90 and Its Client Proteins for Treatment of Prostate Cancer
حسب: Long Chen (315739)
منشور في: (2023)

Supplementary Figures 1-3 from Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL
حسب: Ziju Y. Xu-Monette (15115240)
منشور في: (2023)

Supplementary Figures 1 - 5 from ONC201 Targets AR and AR-V7 Signaling, Reduces PSA, and Synergizes with Everolimus in Prostate Cancer
حسب: Avital Lev (4018193)
منشور في: (2023)

Interview with Dr. Tuveson from <i>nab</i>-Paclitaxel Potentiates Gemcitabine Activity by Reducing Cytidine Deaminase Levels in a Mouse Model of Pancreatic Cancer
حسب: Kristopher K. Frese (14919695)
منشور في: (2023)

Supplementary Figures 1-4 from Nuclear Trapping through Inhibition of Exosomal Export by Indomethacin Increases Cytostatic Efficacy of Doxorubicin and Pixantrone
حسب: Raphael Koch (206532)
منشور في: (2023)

Supplementary Video S1 from Reversal of Chemoresistance in Ovarian Cancer by Co-Delivery of a P-Glycoprotein Inhibitor and Paclitaxel in a Liposomal Platform
حسب: Yilin Zhang (1463938)
منشور في: (2023)

Supplementary Video S2 from Reversal of Chemoresistance in Ovarian Cancer by Co-Delivery of a P-Glycoprotein Inhibitor and Paclitaxel in a Liposomal Platform
حسب: Yilin Zhang (1463938)
منشور في: (2023)

Supplementary Video S3 from Reversal of Chemoresistance in Ovarian Cancer by Co-Delivery of a P-Glycoprotein Inhibitor and Paclitaxel in a Liposomal Platform
حسب: Yilin Zhang (1463938)
منشور في: (2023)

Supplementary Table 8 from Genotype-Selective Combination Therapies for Melanoma Identified by High-Throughput Drug Screening
حسب: Matthew A. Held (14900358)
منشور في: (2023)

Supplementary Table S2 from Selective Inhibition of SIN3 Corepressor with Avermectins as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer
حسب: Yeon-Jin Kwon (15068202)
منشور في: (2023)

Supplementary Table S3 from Selective Inhibition of SIN3 Corepressor with Avermectins as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer
حسب: Yeon-Jin Kwon (15068202)
منشور في: (2023)

Supplemental Figure S1 from Targeting RRM2 and Mutant BRAF Is a Novel Combinatorial Strategy for Melanoma
حسب: Nail Fatkhutdinov (14934183)
منشور في: (2023)

Supplemental Figure S2 from Targeting RRM2 and Mutant BRAF Is a Novel Combinatorial Strategy for Melanoma
حسب: Nail Fatkhutdinov (14934183)
منشور في: (2023)

Supplemental Figure S3 from Targeting RRM2 and Mutant BRAF Is a Novel Combinatorial Strategy for Melanoma
حسب: Nail Fatkhutdinov (14934183)
منشور في: (2023)

Supplemental Figure S4 from Targeting RRM2 and Mutant BRAF Is a Novel Combinatorial Strategy for Melanoma
حسب: Nail Fatkhutdinov (14934183)
منشور في: (2023)

Supplementary Figure S1 from Targeting Homologous Recombination by Pharmacological Inhibitors Enhances the Killing Response of Glioblastoma Cells Treated with Alkylating Drugs
حسب: Nancy Berte (14934423)
منشور في: (2023)

Supplementary Figure S2 from Targeting Homologous Recombination by Pharmacological Inhibitors Enhances the Killing Response of Glioblastoma Cells Treated with Alkylating Drugs
حسب: Nancy Berte (14934423)
منشور في: (2023)

Supplementary Figure S3 from Targeting Homologous Recombination by Pharmacological Inhibitors Enhances the Killing Response of Glioblastoma Cells Treated with Alkylating Drugs
حسب: Nancy Berte (14934423)
منشور في: (2023)

Supplementary Figure 1 from Targeting c-MYC in Platinum-Resistant Ovarian Cancer
حسب: Jeyshka M. Reyes-González (9863660)
منشور في: (2023)

Supplementary Figure 2 from Targeting c-MYC in Platinum-Resistant Ovarian Cancer
حسب: Jeyshka M. Reyes-González (9863660)
منشور في: (2023)

Supplementary Figure 3 from Targeting c-MYC in Platinum-Resistant Ovarian Cancer
حسب: Jeyshka M. Reyes-González (9863660)
منشور في: (2023)

Segmentation and quantitation pipeline for image analysis from Targeting RNA-Polymerase I in Both Chemosensitive and Chemoresistant Populations in Epithelial Ovarian Cancer
حسب: Robert Cornelison (12254519)
منشور في: (2023)